It is thus tempting to speculate that both the direct inhibition of multiple K+ currents and blockades of the vasopressin V2 receptor by TLV or other structurally similar non-peptide compounds produce beneficial effects on patients with hyponatremia or the syndrome of inappropriate antidiuretic hormone secretion [64,65]. The gene discussed is AVPR2; the disease is Hyponatremia.